A detailed history of Ra Capital Management, L.P. transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 11,609,704 shares of FULC stock, worth $37.3 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares
11,609,704
Holding current value
$37.3 Million
% of portfolio
1.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.98 - $9.31 $69.4 Million - $108 Million
11,609,704 New
11,609,704 $72 Million
Q4 2023

Feb 14, 2024

BUY
$3.18 - $6.86 $36.9 Million - $79.6 Million
11,609,704 New
11,609,704 $78.4 Million
Q1 2023

May 15, 2023

BUY
$2.83 - $13.99 $5.95 Million - $29.4 Million
2,103,779 Added 22.13%
11,609,704 $33.1 Million
Q4 2022

Feb 14, 2023

BUY
$5.01 - $8.35 $12.6 Million - $20.9 Million
2,505,925 Added 35.8%
9,505,925 $69.2 Million
Q3 2022

Nov 14, 2022

BUY
$4.92 - $9.1 $34.4 Million - $63.7 Million
7,000,000 New
7,000,000 $56.6 Million

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $167M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.